Investors in Walgreens Boots Alliance, Inc. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights - WBA

1. Shareholders can join a class action against WBA for alleged malpractice. 2. Walgreens is accused of misleading statements regarding regulatory compliance. 3. Allegations suggest Walgreens' revenue from prescriptions is unsustainable. 4. The class period for claims runs from April 2, 2020 to January 16, 2025. 5. Failure to comply with laws could lead to significant reputational damage.

Legal

80

4m saved

Insight

Article

FAQ

Why Bearish?

The allegations of misleading statements raise concerns about WBA's viability, potentially leading to loss of investor trust, similar to past cases of regulatory scrutiny impacting stock prices.

How important is it?

The potential legal implications and reputational risks highlighted in the article directly affect Walgreens' stock, which investors closely monitor.

Why Short Term?

The upcoming March 31, 2025 deadline for lead plaintiffs could lead to immediate investor reactions and price volatility, reminiscent of past class action outcomes where stocks dipped upon legal announcements.

Related Companies

WBA

NEW YORK, Feb. 10, 2025 /PRNewswire/ --

The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).

Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=127859&from=4

CLASS PERIOD:

April 2, 2020 to January 16, 2025

ALLEGATIONS:

The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that:
(i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same;
(ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm;
(iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and
(iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

DEADLINE:

March 31, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=127859&from=4

NEXT STEPS FOR SHAREHOLDERS:

Once you register as a shareholder who purchased shares of WBA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 31, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM?

The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: info@grosslawfirm.com
Phone: (646) 453-8903

SOURCE The Gross Law Firm